BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7534152)

  • 1. Fetal hemoglobin levels in adults.
    Rochette J; Craig JE; Thein SL
    Blood Rev; 1994 Dec; 8(4):213-24. PubMed ID: 7534152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of hemoglobin F synthesis in patients with beta thalassemia.
    Ley TJ; Nienhuis AW
    Annu Rev Med; 1985; 36():485-98. PubMed ID: 2581500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cell stress signaling model of fetal hemoglobin induction: what doesn't kill red blood cells may make them stronger.
    Mabaera R; West RJ; Conine SJ; Macari ER; Boyd CD; Engman CA; Lowrey CH
    Exp Hematol; 2008 Sep; 36(9):1057-72. PubMed ID: 18718415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia.
    Koshy M; Dorn L; Bressler L; Molokie R; Lavelle D; Talischy N; Hoffman R; van Overveld W; DeSimone J
    Blood; 2000 Oct; 96(7):2379-84. PubMed ID: 11001887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disorders of the synthesis of human fetal hemoglobin.
    Manca L; Masala B
    IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of fetal hemoglobin in the treatment of sickle cell disease.
    Fathallah H; Atweh GF
    Hematology Am Soc Hematol Educ Program; 2006; ():58-62. PubMed ID: 17124041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced fetal hemoglobin production by phenylacetate and 4-phenylbutyrate in erythroid precursors derived from normal donors and patients with sickle cell anemia and beta-thalassemia.
    Fibach E; Prasanna P; Rodgers GP; Samid D
    Blood; 1993 Oct; 82(7):2203-9. PubMed ID: 7691251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin.
    Witt O; Monkemeyer S; Rönndahl G; Erdlenbruch B; Reinhardt D; Kanbach K; Pekrun A
    Blood; 2003 Mar; 101(5):2001-7. PubMed ID: 12393499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic induction of fetal hemoglobin synthesis: cellular and molecular mechanisms.
    Yang YM; Pace B
    Pediatr Pathol Mol Med; 2001; 20(1):87-106. PubMed ID: 12673846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic manipulation of fetal hemoglobin synthesis.
    Dover GJ; Humphries RK; Young N; Ley T; Boyer S; Charache S; Nienhuis A
    Prog Clin Biol Res; 1985; 191():447-54. PubMed ID: 2413480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased HbF in adult life.
    Wood WG
    Baillieres Clin Haematol; 1993 Mar; 6(1):177-213. PubMed ID: 7688998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes.
    Dover GJ; Chang VT; Boyer SH; Serjeant GR; Antonarakis S; Higgs DR
    Blood; 1987 Jan; 69(1):341-4. PubMed ID: 2431731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
    Stamatoyannopoulos JA; Nienhuis AW
    Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells.
    Smith RD; Li J; Noguchi CT; Schechter AN
    Blood; 2000 Feb; 95(3):863-9. PubMed ID: 10648397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches.
    Sripichai O; Fucharoen S
    Expert Rev Hematol; 2016 Dec; 9(12):1129-1137. PubMed ID: 27801605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of clinical severity through raised fetal hemoglobin in sickle cell anaemia.
    Ponnazhagan S; Sarkar R
    Indian J Pediatr; 1992; 59(1):85-90. PubMed ID: 1377179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological induction of foetal haemoglobin synthesis in sickle-cell disease.
    Saleh AW; Hillen HF
    Neth J Med; 1997 Nov; 51(5):169-78. PubMed ID: 9455096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH; Voskaridou E; Kutlar A; Loukopoulos D; Koshy M; Ballas SK; Castro O; Barton F
    Am J Hematol; 2003 Feb; 72(2):121-6. PubMed ID: 12555216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of two β globin gene cluster mutations leading to the hereditary persistence of fetal hemoglobin (HPFH) phenotype.
    Hariharan P; Sawant M; Gorivale M; Manchanda R; Colah R; Ghosh K; Nadkarni A
    Mol Biol Rep; 2017 Oct; 44(5):413-417. PubMed ID: 28879539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.